PLoS ONE, 2012 BackgroundThe relationship between menopausal hormone therapy (MHT) and cardiovascular risk remains controversial, with a number of studies advocating the use of MHT in reducing risk of cardiovascular diseases, while others have shown it to increase risk.
Christine L Chiu +6 more
doaj +1 more source
Cost-utility of adjuvant zoledronic acid in patients with breast cancer and low estrogen levels [PDF]
, 2015 BACKGROUND: Adjuvant zoledronic acid (za) appears to improve disease-free survival (dfs) in women with early-stage breast cancer and low levels of estrogen (lle) because of induced or natural menopause.
Lamond, Nathan W D +3 more
core +1 more source
Menopause, micronutrients, and hormone therapy [PDF]
The American Journal of Clinical Nutrition, 2005 Micronutrient and herbal/phytochemical supplements are of increasing interest as potential alternatives to using estrogen therapy in treating menopausal symptoms. This article provides an overview of the questionnaires that assess menopausal symptoms and research efforts to better standardize symptom assessment.
openaire +2 more sources
Menopausal hormone therapy in questions and answers – a manual for physicians of various specialties
Menopause Review, 2019 This manual has been prepared by the Expert Team of the Polish Menopause and Andropause Society for physicians representing various medical specialties who see patients with menopausal symptoms in their daily practice.
Tomasz Paszkowski +5 more
doaj +1 more source
Risk Factors of Hypertension in Menopausal Women in Rejomulyo, Madiun [PDF]
, 2015 Hypertension is a state of blood pressure ≥140 mmHg (systolic) or ≥90 mmHg (diastolic). Incidence of women hypertension in Rejomulyo from January to November 2013 reached 28.4%, in which 87% were menopausal.
Ardiani, H. (Hanifah) +2 more
core +1 more source
Menopause and menopausal hormone therapy in women: cardiovascular benefits and risks
Revista Colombiana de Cardiología, 2018 The last decade has brought many challenges and uncertainties regarding the use of menopausal hormone therapy in women. Two early key studies, the Heart and Estrogen/Progestin Replacement Study (HERS) and the Women's Health Initiative (WHI) failed to ...
Anna Svatikova, Sharonne N. Hayes
doaj +1 more source
The role of Phytoestrogens in the management of menopausal symptoms [PDF]
, 2012 Menopause reflects a change in the woman’s physiological hormonal status and is regarded as a pivotal point in a woman’s life. The commonest symptoms experienced by women during the menopause are hot flushes and night sweats.
Avendonk, Tania van
core
Metabolic, inflammatory and haemostatic effects of a low-dose continuous combined HRT in women with type 2 diabetes: potentially safer with respect to vascular risk? [PDF]
, 2003 BACKGROUND Conventional hormone replacement therapy (HRT) containing conjugated equine oestrogen (CEE) and medroxyprogesterone acetate (MPA) increases triglyceride, C- reactive protein (CRP) and coagulation Factor VII concentrations, potentially ...
Alan J. Jaap +46 more
core +1 more source
Individual choice of menopausal hormone therapy [PDF]
Гинекология, 2016 The goal of anti-aging menopausal hormone therapy (MHT) lies in maintenance and restoration of the major organs and body systems, thus achieving two main effects: increasing life expectancy and improving its quality, which is fully consistent with the ...
T V Ovsyannikova, I A Kulikov
doaj
Dietary determinants of changes in waist circumference adjusted for body mass index - a proxy measure of visceral adiposity [PDF]
, 2010 Background Given the recognized health effects of visceral fat, the understanding of how diet can modulate changes in the phenotype “waist circumference for a given body mass index (WCBMI)”, a proxy measure of visceral adiposity, is deemed necessary ...
A, D.L., van der +16 more
core +2 more sources